Integration of BRAF V600E mutation with contrast-enhanced ultrasound parameters provides complementary diagnostic value for malignant thyroid nodules - Takeaways - MDSpire

Integration of BRAF V600E mutation with contrast-enhanced ultrasound parameters provides complementary diagnostic value for malignant thyroid nodules

  • By

  • Cui, Guihua

  • Wang, Guanlin

  • Song, Chonghui

  • Tian, Ruimeng

  • Li, Kunwei

  • Li, Zhihai

  • Li, Ning

  • April 27, 2026

  • 0 min

Share

  • 1

    The study evaluates the diagnostic efficacy of combining BRAF V600E mutation analysis with CEUS metrics for thyroid nodules.

  • 2

    Among 66 patients, the BRAF V600E mutation was significantly more frequent in malignant thyroid nodules compared to benign ones.

  • 3

    The combined model of BRAF V600E and CEUS time to peak achieved the highest diagnostic accuracy with an AUC of 0.855.

  • 4

    Adding BRAF V600E to CEUS parameters diminished the significance of TTP, highlighting BRAF V600E as a strong predictor of malignancy.

  • 5

    The combined model showed higher specificity than TI-RADS while maintaining comparable sensitivity, indicating fewer false positives.

Original Source(s)

Integration of BRAF V600E mutation with contrast-enhanced ultrasound parameters provides complementary diagnostic value for malignant thyroid nodules

  • by Cui, Guihua , Wang, Guanlin , Song, Chonghui , Tian, Ruimeng , Li, Kunwei , Li, Zhihai , Li, Ning

  • April 27, 2026

Related Content

Super-resolution ultrasound radiomics for pre-FNA prediction of nondiagnostic (Bethesda I) thyroid nodules

JAMA Otolaryngology–Head & Neck Surgery —The Year in Review, 2025

Approach to the Pediatric Patient With Thyroid Nodules